JAC Advance Access originally published online on May 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 964-970
© 2004 The British Society for Antimicrobial Chemotherapy
Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium
Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
Received 12 September 2003; returned 12 November 2003; revised 15 March 2004; accepted 16 March 2004
Objectives: In a previous study with a Salmonella typhimurium strain containing cloned ampCampR from Enterobacter cloacae, it was suggested that ampC expression must be kept at low levels by AmpR to maintain normal growth and virulent phenotype. The purpose of this study was to determine whether findings obtained with a laboratory model can be extended to a virulent clinical isolate of S. typhimurium expressing the plasmid-encoded blaCMY-7.
Methods: Disc induction assays were carried out to investigate inducibility of blaCMY-7. Primer extension and sequence analyses were carried out to map the transcriptional start site of blaCMY-7 and determine the relative expression. Growth and invasion potential of Salmonella strains were monitored by optical density, viable counts and cell invasion assays.
Results: Sequence analysis confirmed the absence of ampR upstream of blaCMY-7 therefore confirming the negative results observed using the disc induction assay. Primer extension analysis mapped the start site of blaCMY-7 transcription within an ISEcp1-like element. The relative expression of blaCMY-7 was
965-fold higher than the expression of a wild-type Citrobacter freundii chromosomal ampC and
4.1-fold higher than ampC expression from a derepressed mutant of C. freundii. Growth and the capacity to invade mammalian cells were not compromised for either the clinical isolate or the S. typhimurium transconjugant containing blaCMY-7. However, a Salmonella transformant containing blaCMY-7 exhibited a compromised phenotype with respect to growth and invasion of mammalian cells.
Conclusion: These findings indicate that the biological cost of high-level AmpC production can be compensated by plasmid-encoded factors and not by regulating ampC expression.
Keywords: blaCMY-7, invasion, IS element, virulence, fitness
* Corresponding author. Tel: +1-402-280-5837; E-mail: ndhanson{at}creighton.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Jacoby AmpC {beta}-Lactamases Clin. Microbiol. Rev., January 1, 2009; 22(1): 161 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Marciano, O. Y. Karkouti, and T. Palzkill A Fitness Cost Associated With the Antibiotic Resistance Enzyme SME-1 {beta}-Lactamase Genetics, August 1, 2007; 176(4): 2381 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, K. M. Townsend, M. Lorentzen, K. S. Gobius, N. Fegan, J. J.-C. Chin, K. A. Bettelheim, N. D. Hanson, J. C. Bensink, and D. J. Trott Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1125 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Schmidtke and N. D. Hanson Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated {beta}-Lactam Resistance. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2030 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, K. M. Townsend, N. D. Hanson, J. M. Bell, H. W. Stokes, K. S. Gobius, S. M. Moss, and D. J. Trott Identification of blaCMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia J. Antimicrob. Chemother., May 1, 2006; 57(5): 840 - 848. [Abstract] [Full Text] [PDF] |
||||




